Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03706430 · ClinicalTrials.gov registry record
Validation of RPVi as a Parameter to Predict Fluid Responsiveness
A clinical trial, sponsored by Masimo Corporation.
- Terminated
- Registry status
- 63
- Enrollment target
NCT03706430 is a clinical trial that was terminated before completion, run by Masimo Corporation. The registered enrollment target is 63 participants.
The verdict
NCT03706430 was terminated before completion, sponsored by Masimo Corporation.
- TERMINATED
- Registry status
- 63 participants
- Enrollment target
Study Summary
This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).
Interventions
- DEVICE Pulse CO-Oximeter sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-09-24 |
| Est. Completion | 2021-10-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03706430
The ClinicalTrials.gov registry entry for NCT03706430 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Pulse CO-Oximeter sensor is the first listed.
NCT03706430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03706430 about?
NCT03706430 is a clinical study titled "Validation of RPVi as a Parameter to Predict Fluid Responsiveness". This is a prospective, nonrandomized, sequential data collection study to evaluate the ability of RPVi to predict fluid responsiveness in comparison with other dynamic parameters including stroke volume variation (SVV) and/or pulse pressure variation (PPV).
What is the current status of trial NCT03706430?
This trial is currently terminated. The enrollment target is 63 participants. The study started on 2018-09-24. Estimated completion is 2021-10-20.
What interventions are being tested in trial NCT03706430?
The interventions under investigation include: Pulse CO-Oximeter sensor (DEVICE).
Who is sponsoring clinical trial NCT03706430?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.